Insider Selling: Bryan Kleinlein Sells 227,626 Shares of Lexicon Pharmaceuticals Stock (LEXG)
Lexicon Pharmaceuticals (NASDAQ:LEXG) CFO Bryan Kleinlein sold 227,626 shares of the stock on the open market in a transaction dated Friday, October 25th. The stock was sold at an average price of $0.13, for a total value of $29,591.38. Following the completion of the transaction, the chief financial officer now directly owns 40,323 shares of the company’s stock, valued at approximately $5,242. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Lexicon Pharmaceuticals (NASDAQ:LEXG) traded up 3.57% during mid-day trading on Friday, hitting $0.09. The stock had a trading volume of 353,146 shares. Lexicon Pharmaceuticals has a 52 week low of $0.09 and a 52 week high of $0.41. The stock has a 50-day moving average of $0.15 and a 200-day moving average of $0.17. The company’s market cap is $5.7 million.
Lexicon Pharmaceuticals, Inc (NASDAQ:LEXG) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.